Lower doses of chemotherapy or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Tumor Cells, Cultured Bone Marrow Skin

Organisms4

Mice, Nude Rats, Sprague-Dawley Mice, Inbred BALB C Rats, Wistar

Diseases64

Radiation Injuries Breast Neoplasms Neoplasms Neoplasms, Radiation-Induced Lung Neoplasms Radiation Injuries, Experimental Radiation Pneumonitis Neoplasm Recurrence, Local Brain Neoplasms Adenocarcinoma Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis Neutropenia Hodgkin Disease Lymphoma, Non-Hodgkin Carcinoma, Squamous Cell Vomiting Ovarian Neoplasms Nausea Leukopenia Head and Neck Neoplasms Colorectal Neoplasms Testicular Neoplasms Recurrence Bone Neoplasms Acute Radiation Syndrome Liver Neoplasms Lymphoma Neoplasms, Germ Cell and Embryonal Carcinoma Osteosarcoma Lymphatic Metastasis Leukemia, Radiation-Induced Disease Progression Thrombocytopenia Sarcoma Radiodermatitis Peritoneal Neoplasms Germinoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Stomach Neoplasms Neoplasms, Second Primary Stomatitis Leukemia, Myeloid, Acute Pancreatic Neoplasms Glioma Disease Models, Animal Colonic Neoplasms Rectal Neoplasms Glioblastoma Nasopharyngeal Neoplasms Retroperitoneal Neoplasms Neoplasm, Residual Central Nervous System Neoplasms Esophageal Neoplasms Neoplasms, Experimental Medulloblastoma Mediastinal Neoplasms Hematologic Diseases Lymphoma, Large B-Cell, Diffuse Seminoma Abnormalities, Radiation-Induced Mucositis Cerebellar Neoplasms

Chemicals and Drugs57

Antineoplastic Agents Cisplatin Cyclophosphamide Doxorubicin Etoposide Methotrexate Paclitaxel Carboplatin Vinblastine Taxoids Deoxycytidine Antimetabolites, Antineoplastic Bleomycin Antineoplastic Agents, Alkylating Ifosfamide Radiation-Sensitizing Agents Organoplatinum Compounds Antineoplastic Agents, Phytogenic Cytarabine Radiation-Protective Agents Anthracyclines Dacarbazine Antibiotics, Antineoplastic Carmustine Granulocyte Colony-Stimulating Factor Antibodies, Monoclonal Lomustine Cobalt Radioisotopes Camptothecin Antibodies, Monoclonal, Humanized Melphalan Tumor Markers, Biological Antiemetics Platinum Compounds Mitomycin Tegafur Mitoxantrone Thiotepa Recombinant Proteins Daunorubicin Drug Combinations Radiopharmaceuticals Cesium Radioisotopes Bridged Compounds Vindesine Radioisotopes Dexamethasone Platinum Angiogenesis Inhibitors Tumor Suppressor Protein p53 Oxonic Acid Prednisolone Antibodies, Monoclonal, Murine-Derived Amifostine Nimustine Radioactive Fallout Receptor, erbB-2

Analytical, Diagnostic and Therapeutic Techniques and Equipment89

Antineoplastic Combined Chemotherapy Protocols Radiation Dosage Chemotherapy, Adjuvant Dose-Response Relationship, Radiation Combined Modality Therapy Treatment Outcome Radiation Monitoring Drug Administration Schedule Radiotherapy Dosage Disease-Free Survival Radiotherapy Neoadjuvant Therapy Survival Analysis Neoplasm Staging Survival Rate Prognosis Radiometry Radiation Injuries, Experimental Radiotherapy, Adjuvant Follow-Up Studies Induction Chemotherapy Dose Fractionation Administration, Oral Infusions, Intravenous Prospective Studies Clinical Trials as Topic Salvage Therapy Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Chemotherapy, Cancer, Regional Perfusion Radiotherapy, Conformal Tomography, X-Ray Computed Transplantation, Autologous Chemoradiotherapy Cranial Irradiation Kaplan-Meier Estimate Lethal Dose 50 Drug Evaluation Feasibility Studies Injections, Intravenous Double-Blind Method Randomized Controlled Trials as Topic Hematopoietic Stem Cell Transplantation Brachytherapy Palliative Care Infusions, Intra-Arterial Whole-Body Irradiation Body Burden Hyperthermia, Induced Drug Therapy Radiotherapy, High-Energy Radiation Hybrid Mapping Actuarial Analysis Thermoluminescent Dosimetry Risk Factors Xenograft Model Antitumor Assays Multivariate Analysis Random Allocation Immunohistochemistry Bone Marrow Transplantation Risk Assessment Injections, Subcutaneous Disease Models, Animal Mastectomy Analysis of Variance Injections, Intraperitoneal Proportional Hazards Models Positron-Emission Tomography Infusions, Parenteral Neoplasm Transplantation Area Under Curve Fluoroscopy Tumor Burden Cohort Studies Radiosurgery Treatment Failure Clinical Trials, Phase III as Topic Synchrotrons Maintenance Chemotherapy Neoplasms, Experimental Predictive Value of Tests Particle Accelerators Drug Screening Assays, Antitumor Leukocyte Count Retrospective Studies Fatal Outcome Pilot Projects Drug Delivery Systems Models, Biological

Phenomena and Processes30

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Radiation Dose-Response Relationship, Drug Time Factors Cosmic Radiation Gamma Rays Background Radiation Drug Resistance, Neoplasm Ultraviolet Rays Radiation Effects X-Rays Apoptosis Cell Survival DNA Damage Lethal Dose 50 Drug Synergism DNA Repair Linear Energy Transfer Drug Interactions Area Under Curve Cell Proliferation Leukocyte Count Radiation, Nonionizing Beta Particles Electromagnetic Radiation Gene Expression Regulation, Neoplastic Half-Life

Disciplines and Occupations5

Radiation Oncology Radiobiology Immunohistochemistry Medical Oncology Radiation Genetics

Anthropology, Education, Sociology and Social Phenomena2

Nuclear Warfare Quality of Life

Technology, Industry, Agriculture1

Nuclear Weapons

Humanities1

Quality of Life

Information Science5

Survival Rate Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Radiotherapy, Conformal Fatal Outcome

Health Care45

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Treatment Outcome Radiation Monitoring Radiation Protection Disease-Free Survival Survival Analysis Survival Rate Radiation Injuries, Experimental Cosmic Radiation Follow-Up Studies Ultraviolet Rays Prospective Studies Radiation Effects Clinical Trials as Topic Kaplan-Meier Estimate Acute Radiation Syndrome Radioactive Hazard Release Feasibility Studies Double-Blind Method Randomized Controlled Trials as Topic Palliative Care Body Burden Relative Biological Effectiveness Actuarial Analysis Thermoluminescent Dosimetry Risk Factors Multivariate Analysis Random Allocation Risk Assessment Age Factors Analysis of Variance Proportional Hazards Models Radiation Genetics Area Under Curve Cohort Studies Treatment Failure Clinical Trials, Phase III as Topic Predictive Value of Tests Retrospective Studies Fatal Outcome Abnormalities, Radiation-Induced Pilot Projects Radioactive Fallout

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Radiation Dosage Chemotherapy, Adjuvant Radiation, Ionizing Radiation Injuries Dose-Response Relationship, Radiation Combined Modality Therapy Radiation Tolerance Radiation Antineoplastic Agents Treatment Outcome Cisplatin Radiation Monitoring Radiation Protection Cyclophosphamide Doxorubicin Drug Administration Schedule Radiotherapy Dosage Disease-Free Survival Breast Neoplasms Radiotherapy Neoadjuvant Therapy Survival Analysis Dose-Response Relationship, Drug Neoplasm Staging Radiation Oncology Etoposide Time Factors Survival Rate Prognosis Neoplasms Radiometry Neoplasms, Radiation-Induced Lung Neoplasms Radiation Injuries, Experimental Methotrexate Radiation Pneumonitis Cosmic Radiation Neoplasm Recurrence, Local Paclitaxel Gamma Rays Carboplatin Radiotherapy, Adjuvant Vinblastine Follow-Up Studies Taxoids Deoxycytidine Induction Chemotherapy Antimetabolites, Antineoplastic Background Radiation Dose Fractionation Drug Resistance, Neoplasm Bleomycin Antineoplastic Agents, Alkylating Brain Neoplasms Administration, Oral Ultraviolet Rays Adenocarcinoma Ifosfamide Radiation-Sensitizing Agents Organoplatinum Compounds Infusions, Intravenous Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis Prospective Studies Antineoplastic Agents, Phytogenic Cytarabine Radiation Effects Clinical Trials as Topic Cell Line, Tumor Salvage Therapy Radiotherapy, Intensity-Modulated Neutropenia Radiation-Protective Agents Hodgkin Disease Anthracyclines Lymphoma, Non-Hodgkin Carcinoma, Squamous Cell Vomiting Ovarian Neoplasms Radiotherapy Planning, Computer-Assisted Nausea Dacarbazine Chemotherapy, Cancer, Regional Perfusion Leukopenia Antibiotics, Antineoplastic Radiotherapy, Conformal Tomography, X-Ray Computed Carmustine Head and Neck Neoplasms Colorectal Neoplasms Testicular Neoplasms Transplantation, Autologous X-Rays Chemoradiotherapy Apoptosis Cranial Irradiation Cell Survival Kaplan-Meier Estimate Recurrence

No FAQ available that match "lower doses of chemotherapy or radiation"